Latest BBS-Bioactive Bone Substitutes News & Updates

See the latest news and media coverage for BBS. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
BBS-Bioactive Bone Substitutes (BBS)

Developer of bioactive bone graft substitutes

bbs-artebone.fi
Headquarters
Oulu, Finland
Founded year
2003
Company type
Private company
Number of employees
10–50

Last updated

Latest news about BBS-Bioactive Bone Substitutes (BBS)

In short: BBS faced severe financial distress, leading to bankruptcy and the cancellation of its 2024 financial statements after failed funding efforts.

Company announcements

  • BBS

    BBS announces 2025 financial calendar

    Financial statements release on February 21, annual report in March, half-year report on August 29. AGM on April 29. Silent period precedes reports.

  • BBS

    BBS announces no financial statements due to bankruptcy

    The bankruptcy estate will not publish the 2024 financial statement release or other previously announced statements.

  • BBS

    FIN-FSA imposes penalty payments on BBS board members

    The authority fined Pekka Jalovaara €4,000, Jarmo Halonen €5,000, and former member Ahti Paananen €9,000 for late transaction notifications. The decision is appealable.

  • BBS

    BBS announces CEO Juliusz Rakowski terminates agreement

    Rakowski continues until February 28, 2025. He expresses gratitude to the Board, shareholders, partners, and employees.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about BBS

Track BBS and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

BBS competitors & trending companies

Browse news for competitors to BBS and other trending companies.